Rupee rises 24 paise to 74.38 against U.S. Dollar in early trade

In the previous session, the rupee had settled at 74.62 against the U.S. Dollar

November 17, 2020 12:15 pm | Updated 12:20 pm IST - Mumbai

At the interbank Forex market, the domestic unit opened strong at 74.43 against the U.S. Dollar, then gained further ground to touch 74.38, registering a rise of 24 paise over its last close.

At the interbank Forex market, the domestic unit opened strong at 74.43 against the U.S. Dollar, then gained further ground to touch 74.38, registering a rise of 24 paise over its last close.

The rupee appreciated by 24 paise to 74.38 against the U.S. Dollar in opening trade on Tuesday, tracking positive domestic equities amid improved risk appetite.

Forex dealers said a weak Dollar overseas supported the local unit.

At the interbank Forex market, the domestic unit opened strong at 74.43 against the U.S. Dollar, then gained further ground to touch 74.38, registering a rise of 24 paise over its last close.

In the previous session, the rupee had settled at 74.62 against the U.S. Dollar.

“Global risk sentiment continues to remain positive. After Pfizer, Moderna’s vaccine trials have yielded promising results (trials indicate it is 94.5 % effective in preventing Coronavirus and vaccine also does not need to be stored at ultra-low temperatures unlike Pfizer’s),” said Abhishek Goenka, Founder and CEO, IFA Global.

Mr. Goenka further said that “the Rupee has been the worst performing Asian currency year to date. With inflation currently high primarily on account of higher food prices, we believe the RBI will gradually continue to weaken the Rupee in relative terms while continuing to manage volatility”.

Meanwhile, the Dollar index, which gauges the greenback’s strength against a basket of six currencies, dipped 0.15 % to 92.50.

According to a Reliance Securities research note, “the safe-haven appeal for the greenback reduced after Moderna Inc became the second U.S. company in a week to report positive results from its COVID-19 vaccine trial”.

On the equity front, the 30-share BSE index rallied 274.66 points or 0.63 % to scale the fresh peak of 43,912.64. Similarly, the broader NSE Nifty gained 74.45 points or 0.58 % to a lifetime high of 12,854.70.

Brent crude futures, the global oil benchmark, rose 0.68 % to $44.12 per barrel.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.